Phase 2 case-control status by Epstein–Barr virus (EBV) and cytomegalovirus (CMV) antibody pattern.

Publication Details

Journal
Figshare
Published
2025-01-28
DOI
https://doi.org/10.1371/journal.pmed.1004511.s012
Primary Topic
Cytomegalovirus and herpesvirus research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase 2 case-control status by Epstein–Barr virus (EBV) and cytomegalovirus (CMV) antibody pattern.

Figshare
Cytomegalovirus and herpesvirus research
article

Phase 2 case-control status by Epstein–Barr virus (EBV) and cytomegalovirus (CMV) antibody pattern.

article en

Abstract

No abstract available for this paper.
Figshare
Openalex Percentile: Top 46%
Cytomegalovirus and herpesvirus research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Phase 2 case-control status by Epstein–Barr virus (EBV) and cytomegalovirus (CMV) antibody pattern. · Figshare (2025) | TGRS Research Map | TGRS